|
Selected(0)Clear
Items/Page: Sort: |
| Consensual settlement of competition disputes in China: a call for conditional arbitrability Journal article
Svetlicinii, A.. Consensual settlement of competition disputes in China: a call for conditional arbitrability[J]. Asia Pacific Law Review, 2024, 32(2), 487-503.
Authors: ; et al.
  Favorite | TC[WOS]:0 TC[Scopus]:0 | Submit date：2024/05/13
China Arbitration Competition Law Courts Public Policy |
| Chinese Anti-Monopoly Law 2022 Amendment concerning Platform Economy Presentation
会议地点: The International League of Competition Law (LIDC) Working Group on Data Regulation & Digital Economy, 会议日期: 31 August 2022, 报告日期: 2022-08-31
Authors: Svetlicinii, A. 
Favorite | | Submit date：2022/09/02
China Anti-monopoly Law Competition Law Antitrust Merger Control |
| State Capitalism in ASEAN: The State-Owned Enterprises Under the ASEAN Regional Competition Policy Book chapter
出自: Asian Yearbook of International Economic Law 2022, Cham:Springer, 2021, 页码:193-203
Authors: Svetlicinii, A.
Favorite | | Submit date：2022/07/27
Asean Competition Law State-owned Enterprise |
| The State-Owned Enterprises under the ASEAN Regional Competition Policy: Insights from the European Competition Network Journal article
Svetlicinii, A.. The State-Owned Enterprises under the ASEAN Regional Competition Policy: Insights from the European Competition Network[J]. KLRI Journal of Law and Legislation, 2021, 11(2), 6-46.
Authors: Svetlicinii, A.
Favorite | | Submit date：2022/07/27
Asean Competition Law Competition Policy State-owned Enterprises Competitive Neutrality Regional Economic Integration |
| Between settlement and infringement: the Court of Justice rules on 'hybrid procedure' in Pometon case Other
2021-03-22
Authors: Svetlicinii, A.
Favorite | | Submit date：2022/08/16
Competition Law Cartel Settlement Eu Law European Commission |
| Chinese State Owned Enterprises and EU Merger Control Book
Svetlicinii, A.. Chinese State Owned Enterprises and EU Merger Control[M]. New York:Routledge, 2020.
Authors: Svetlicinii, A.
Favorite | | Submit date：2022/07/27
Competition Law Merger Control State Owned Enterprise China European Union |
| The Acquisitions of the Chinese State-Owned Enterprises under the EU Merger Control Regime: Time to Revisit the Concepts of 'Control' and 'Single Economic Entity'? Journal article
Svetlicinii, A.. The Acquisitions of the Chinese State-Owned Enterprises under the EU Merger Control Regime: Time to Revisit the Concepts of 'Control' and 'Single Economic Entity'?[J]. Boletim da Faculdade de Direito da Universidade de Macau, 2020, 259-273.
Authors: Svetlicinii, A.
Favorite | | Submit date：2022/07/28
competition law merger control China European Commission SASAC state-owned enterprise Belt and Road Initiative single economic entity economic concentration state control state ownership |
| The Interactions of Competition Law and Investment Law: The Case of Chinese State-Owned Enterprises and EU Merger Control Regime Book chapter
出自: Handbook of International Investment Law and Policy, Singapore:Springer, Singapore, 2019, 页码:1-21
Authors: Svetlicinii, A.
Favorite | TC[Scopus]:0 | Submit date：2022/07/27
State-owned Enterprise China European Union Merger Control Foreign Direct Investment National Security Competition Law Investment Law |
| A Nulidade de Contratos Como Consequência da Violação das Normas de Direito da Concorrência Journal article
Moreira, João Ilhão. A Nulidade de Contratos Como Consequência da Violação das Normas de Direito da Concorrência[J]. Boletim da Faculdade de Direito da Universidade de Coimbra, 2019, 95, 723-746.
Authors: Moreira, João Ilhão
Favorite | | Submit date：2022/08/27
Competition Law Private Enforcement Invalidity Optimal Sanction |
| Off-label use of medicines under scrutiny: Between competition law and pharma regulations Journal article
Svetlicinii, A.. Off-label use of medicines under scrutiny: Between competition law and pharma regulations[J]. Medicine and Law, 2019, 38(2), 165-182.
Authors: Svetlicinii, A.
Favorite | TC[WOS]:1 TC[Scopus]:0 IF:0.1/0.1 | Submit date：2020/12/04
Competition Law European Union Off-label Prescription Off-label Promotion Pharmaceuticals Pharmacovigilance |
